Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Mesenchymal Stem Cells Treatment for Erectile Dysfunction in Diabetic Rats.

Kim SW., Zhu GQ., Bae WJ.

Narrative Review on Type 1 Diabetes, published in Sex Med Rev (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Sex Med Rev (2019)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
31653438
DOI
10.1016/j.sxmr.2019.09.003
Citations
15

Abstract (original English)

Introduction Aging men with diabetes mellitus are more easily suffering from erectile dysfunction (ED), which was poor to respond to drugs. Mesenchymal stem cell treatment (MSCT) offers us an alternative approach that might reverse diabetes mellitus erectile dysfunction (DMED). Aim The aim of this study was to review the current studies investigating mesenchymal stem cell approach in diabetic rat models of ED for future research. Methods A medical literature search was performed in PubMed by using the keywords including erectile dysfunction, mesenchymal stem cells, diabetes mellitus, and rat model. Main outcome measure Representative studies on DMED rats treated by MSCT were reviewed. Results Streptozocin-induced type 1 diabetes mellitus rats were used in most studies because of cost and convenience. With the development of stem cell treatment for DMED research, many kinds of stem cells were used in animal experiment, such as bone marrow-derived mesenchymal stem cells, adipose-derived stem cells, human umbilical cord blood mononuclear cells, muscle-derived stem cells, urine-derived stem cells, neural crest stem cells, and endothelial progenitor cells. Although diverse stem cells were applied for DMED treatment, the mechanism behind these approaches was identical, including improving vascular injury, recovering smooth muscle, restoring neuronal cells, inhibiting the generation o

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsDiabetes ComplicationsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Erectile DysfunctionMaleMesenchymal Stem Cell TransplantationRats

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research